Published in Nat Commun on January 29, 2016
Correlation of an epigenetic mitotic clock with cancer risk. Genome Biol (2016) 0.82
Increased DNA methylation variability in type 1 diabetes across three immune effector cell types. Nat Commun (2016) 0.80
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution. Nat Commun (2016) 0.76
Stochastic epigenetic outliers can define field defects in cancer. BMC Bioinformatics (2016) 0.76
A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies. BMC Bioinformatics (2017) 0.75
Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy. Prostate (2016) 0.75
Epigenetic and genetic deregulation in cancer target distinct signaling pathway domains. Nucleic Acids Res (2016) 0.75
The multi-omic landscape of transcription factor inactivation in cancer. Genome Med (2016) 0.75
Correcting for cell-type heterogeneity in DNA methylation: a comprehensive evaluation. Nat Methods (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature (2009) 18.08
The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol (2010) 13.99
Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer (1953) 11.45
Integrative analysis of 111 reference human epigenomes. Nature (2015) 10.32
Architecture of the human regulatory network derived from ENCODE data. Nature (2012) 10.28
Cancer as an evolutionary and ecological process. Nat Rev Cancer (2006) 9.33
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78
Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics (2011) 7.38
Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet (2006) 6.71
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics (2014) 5.93
Charting a dynamic DNA methylation landscape of the human genome. Nature (2013) 5.80
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics (2012) 4.95
Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics (2013) 4.61
An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One (2009) 3.33
Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell (2012) 2.94
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat Genet (2015) 2.29
MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet (2007) 2.14
Field effect in cancer-an update. Ann Clin Lab Sci (2009) 1.91
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med (2012) 1.65
Genetic reconstruction of individual colorectal tumor histories. Proc Natl Acad Sci U S A (2000) 1.63
Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array. Epigenetics Chromatin (2013) 1.62
Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions. Bioinformatics (2012) 1.51
Toward understanding and exploiting tumor heterogeneity. Nat Med (2015) 1.51
An integrative network algorithm identifies age-associated differential methylation interactome hotspots targeting stem-cell differentiation pathways. Sci Rep (2013) 1.26
Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity. Nature (2015) 1.22
Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer. JAMA Oncol (2015) 1.19
An integrative multi-scale analysis of the dynamic DNA methylation landscape in aging. PLoS Genet (2015) 1.13
Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development. PLoS Med (2013) 1.10
A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control. Bioinformatics (2014) 1.09
Estimation of the content of fat and parenchyma in breast tissue using MRI T1 histograms and phantoms. Magn Reson Imaging (2005) 1.08
Secreted frizzled related proteins: Implications in cancers. Biochim Biophys Acta (2013) 1.04
Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction. Oncogene (2011) 1.02
Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists. BMC Cancer (2014) 0.98
The dynamics of DNA methylation covariation patterns in carcinogenesis. PLoS Comput Biol (2014) 0.96
Cell-composition effects in the analysis of DNA methylation array data: a mathematical perspective. BMC Bioinformatics (2015) 0.95
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer. Nat Genet (2015) 0.95
A Molecular Portrait of High-Grade Ductal Carcinoma In Situ. Cancer Res (2015) 0.91
DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer. Clin Epigenetics (2015) 0.87
Epigenetic field defects in progression to cancer. World J Gastrointest Oncol (2013) 0.86
Clonal diversity in tumor progression. Nat Genet (2006) 0.83
Body mass index associated with genome-wide methylation in breast tissue. Breast Cancer Res Treat (2015) 0.81